In conclusion, all together, our results suggest the possibility that the persistently high E2 levels associated with obesity leads to ESR1 downregulation in adipocytes and reduced E2 sensitivity, which in turn results in attenuated fat mass loss in response to T therapy. Oestrogen resistance...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.